Background: Drug-induced interstitial lung disease (DIILD) occurs as a result of numerous
agents, but the risk often only becomes apparent after the marketing authorisation of such …

Interstitial lung disease (ILD) secondary to drug-induced lung injury is an increasingly
common cause of morbidity and mortality. The number of drugs associated with the …

With an increasing number of therapeutic drugs, the list of drugs that is responsible for
severe pulmonary disease also grows. Many drugs have been associated with pulmonary …

Background Drug-induced interstitial lung disease (DIILD) is a form of interstitial lung
disease resulting from exposure to drugs causing inflammation and possibly interstitial …

The widespread use of high-resolution computed tomography in clinical and research
settings has increased the detection of interstitial lung abnormalities (ILA) in asymptomatic …

Drug-induced interstitial lung disease (DILD) is not uncommon and has many clinical
patterns, ranging from benign infiltrates to life-threatening acute respiratory distress …

Acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) has been defined as an acute,
clinically significant deterioration that develops within less than 1 month without obvious …

Drug-associated interstitial lung disease (ILD) is not uncommon, with diverse patterns
ranging from benign infiltrates to the potentially fatal acute respiratory distress syndrome. As …

Interstitial Lung Diseases (ILDs) represent a heterogeneous group of pathologies, which
may be related to different causes. A low percentage of these lung diseases may be …

Symptoms of drug-associated interstitial lung disease (ILD) are nonspecific and can be
difficult to distinguish from a number of illnesses that commonly occur in patients with non …